{
  "name" : "_cyber.sci-hub.se_MTAuMTAxNi9qLmJpb21hdGVyaWFscy4yMDE2LjA0LjAwNg==_kalluru2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Nano-Graphene Oxide-mediated In vivo Fluorescence Imaging and Bimodal Photodynamic and Photothermal Destruction of Tumors",
    "authors" : [ "Poliraju Kalluru", "Raviraj Vankayala", "Chi-Shiun Chiang", "Kuo Chu Hwang" ],
    "emails" : [ "kchwang@mx.nthu.edu.tw" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Accepted Manuscript\nNano-Graphene Oxide-mediated In vivo Fluorescence Imaging and Bimodal Photodynamic and Photothermal Destruction of Tumors Poliraju Kalluru, Raviraj Vankayala, Chi-Shiun Chiang, Kuo Chu Hwang\nPII: S0142-9612(16)30103-X DOI: 10.1016/j.biomaterials.2016.04.006 Reference: JBMT 17446\nTo appear in: Biomaterials\nReceived Date: 5 January 2016 Revised Date: 26 March 2016 Accepted Date: 8 April 2016\nPlease cite this article as: Kalluru P, Vankayala R, Chiang C-S, Hwang KC, Nano-Graphene Oxidemediated In vivo Fluorescence Imaging and Bimodal Photodynamic and Photothermal Destruction of Tumors, Biomaterials (2016), doi: 10.1016/j.biomaterials.2016.04.006.\nThis is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nNano-Graphene Oxide-mediated In vivo Fluorescence Imaging and Bimodal Photodynamic and Photothermal Destruction of Tumors\nPoliraju Kalluru1, Raviraj Vankayala1, Chi-Shiun Chiang2, and Kuo Chu Hwang1*\n1Department of Chemistry, 2Department of Biomedical Engineering and Environmental Sciences,\nNational Tsing Hua University, Hsinchu 30013, Taiwan ROC\n* To whom correspondence should be addressed, E-mail: kchwang@mx.nthu.edu.tw\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nAbstract: Cancer is one of the major life-threatening diseases among human beings. Developing a simple, cost-effective and biocompatible approach to treat cancers using ultra-low doses of light is a grand challenge in clinical cancer treatments. In this study, we report for the first time that nano-sized graphene oxide (GO) exhibits single-photon excitation wavelength dependent photoluminescence in the visible and short near-infrared (NIR) region, suitable for in vivo multi-color fluorescence imaging. We also demonstrate in both in vitro and in vivo experiments to show that nano GO can sensitize the formation of singlet oxygen to exert combined nanomaterial-mediated photodynamic therapeutic (NmPDT) and photothermal therapy (NmPTT) effects on the destruction of B16F0 melanoma tumors in mice using ultra-low doses (~0.36 W/cm2) of NIR (980 nm) light. The average half-life span of the mice treated by the GO-PEG-folate-mediated NmPDT effects is beyond 30 days, which is ~1.8 times longer than the mice treated with doxorubicin (17 days). Overall, the current study points out a successful example of using GO-PEG-folate nanocomposite as a theranostic nanomedicine to exert simultaneously in vivo fluorescent imaging as well as combined NmPDT and NmPTT effects for clinical cancer treatments.\nKeywords: graphene oxide, photoluminescence, singlet oxygen, photodynamic therapy, photothermal therapy, near infra-red light.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n1"
    }, {
      "heading" : "1. Introduction",
      "text" : "Cancer is one of the death-leading diseases for human beings, accounting for ~15% of the total human deaths [1]. Among various cancer therapeutic treatment technologies, photodynamic therapy (PDT) is emerging, owing to its non-invasiveness, reduced side-effects, circumventing multiple drug-resistance problems, causing less damage to non-cancerous tissues and low systemic cytotoxicity [2]. In PDT, the malignant cells are selectively killed by the intracellular reactive oxygen species (ROS), such as, singlet oxygen (1O2), produced by the photosensitizers (PS) in the presence of molecular oxygen and light [2,3]. The clinically used organic PS-mediated PDT has many drawbacks, such as poor photostability, poor water dispersibility, low light absorbing capability and inability to be activated by the near infra-red light (NIR; >800 nm), which can facilitate deep tissue penetration [4]. In the modern era, the growth and development of nanotechnology provides a hope for the long-lasting challenges in clinical biomedicine [4]. In this regard, significant research efforts were devoted to developing various types of nanomaterials for biomedical diagnosis and therapy. Previously, semiconducting quantum dots conjugated with organic PS were reported as PDT reagents for killing cancer cells. However, their acute cytotoxicity effects constituting from the heavy metals (for example, cadmium and selenium) and extremely low singlet oxygen quantum yields severly restricted its use in the real-world clinical applications [5]. Alternatively, fullerenes and TiO2 nanoparticles were also reported for singlet oxygen sensitization upon UV light excitation. However, their applicability for the PDT treatments are limited owing to the negligible tissue penetration depths of UV light [6,7]. Very recently, near infra-red light activatable metal nanostructures, such as, gold nanorods, nanoshells, nanoechnius, tungsten oxide nanowires and copper sulphide (CuS) nanoparticles were reported as nanomaterialmediated photodynamic therapeutic (NmPDT) reagents for the effective destruction of solid tumors [8-14]. Although, metal nanostructures were highly efficient in killing the cancer cells or solid tumors upon NIR light excitation, their localized surface plasmons (LSPRs) tends to\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n2\nshift or drop upon laser exposure and hence exhibit significant instability and photothermal reshaping [15,16]. In addition, the significant cytotoxicity effects orginated from the cationic surfactants (for example, CTAB) used in the fabrication process and their poor circulation times in the biological bodies can severely limit its applicability in clinical PDT treatments [17]. Therefore, it is highly desired to develop an effective and biocompatible NIR light activatable reagent, which can mediate photodynamic therpaeutic effects on destructing cancer cells operated under ultra-low laser doses.\nIn the recent years, carbon nanostructures have gained significant attention owing to its wide variety of applications in the fields of environmental remediation, energy harvesting, electronics and biomedicine [18]. Previously, it was demonstrated that carbon nanostructures, such as, graphene oxide (GO), reduced graphene oxide (rGO) and single- and multi-walled carbon nanotubes (SWCNTs & MWCNTs) can act as nanocarriers to carry DNAs, RNAs and anticancer drugs for the cancer therapeutic treatments [19-21]. In addition, it was also well documented that these carbon nanostructures can act as nanomaterial-mediated photothermal therapy (NmPTT) reagents upon absorbing the incoming NIR light and converting the photon energy into heat via non-radiative decay transitions for the destruction of cancer cells [22-24]. However, using very high laser powers (1 ~ 15 W/cm2)[25] are practically not feasible for the real time clinical treatments, as the laser powers are far higher than the threshold values for skin tolerance (Maximum Permissible Exposure of skin for 808 and 980 nm wavelengths being 330~350 mW/cm2 with an exposure time of 10~1000 s) prescribed by ANSI (National Standards Institute) [26]. As a brief overview, the laser wavelengths, laser light intensities and irradiation times were summarized for various carbon nanostructures mediated PTT effects reported in the literature (see Table 1) [22,25,27-31]. In addition to their intrinsic photothermal properties, it was also reported that semiconducting-SWCNTs can mediate in vitro photodynamic therapeutic effects very efficiently than metallic SWCNTs upon 808 nm light excitation without adding organic photosensitizers [32]. Very recently, graphene\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n3\nquantum dots based NmPDT reagent was reported for the highly efficient in vivo cancer therapy activatable using blue light and 660 nm short NIR light [33, 34]. Although, graphene quantum dots exhibited a very high singlet O2 quantum yield of ~1.3, their structure is still unclear and moreover, their 660 nm short NIR light activation cannot promise the treatment of deep-tissue buried tumors [33]. Therefore, it is urgently needed to develop new biocompatible nanomaterials which can effectively mediate the photodynamic therapeutic destruction of solid tumors upon ultra-low laser doses of NIR light.\nTo the best of our knowledge, the current work demonstrated to show that nano-sized graphene oxide can exhibit wavelength dependent single-photon excitation-induced photoluminescence in the short NIR and visible region, which is suitable for the in vivo fluorescence imaging operated using inexpensive laser setups using low laser doses as well as can sensitize the generation of 1O2 and mediate bimodal NmPDT and NmPTT effects on killing the B16F0 melanoma tumors effectively under ultra-low laser doses of NIR light excitation. Overall, such unique properties of graphene oxide in a single biomedical platform can be useful to the clinical treatment of cancers."
    }, {
      "heading" : "2. Materials and Methods",
      "text" : ""
    }, {
      "heading" : "2.1 Synthesis of nano-graphene oxide",
      "text" : "In a typical experiment, graphite flakes were mixed with NaCl (1:5 wt%) and finely grounded for 10 min. To this it was added 100 mL of distilled water, so that the NaCl gets dissolved and then subjected to filtration. The remaining graphite flakes were further mixed with 23 mL of 98% H2SO4 and then subjected to stirring for 8 h. Then 3 g of KMnO4 was gently added to the reaction mixture upon constant stirring. The reaction mixture was stirred for ~30 min at 35 to 40° C and then for ~45 min at 65-80 °C. To this solution, 45 mL of deionized water was added and the contents were further refluxed for 0.5 h and the reaction\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n4\nwas stopped by adding deionized water and 30% H2O2 solution and upon repeated centrifugations and filtrations with 5% HCl, the purified graphene oxide was obtained."
    }, {
      "heading" : "2.2 Synthesis of GO-PEG-folate",
      "text" : "In a typical experiment, 40 mg of as synthesized GO, 22.9 mg N, N'Dicyclohexylcarbodiimide (DCC) and 31.9 mg N-hydroxy succinimide (NHS) were added in a sample vial containing 10 mL DMSO and then subjected to stirring at room temperature in a N2 atmosphere for 2 h to activate the carboxylic groups present on the surface of GO. To the same solution, 200 mg of NH2-PEG-folate was added and stirred for another 24 h. Then, the mixture was washed and centrifuged with water and ethanol for several times to yield the pure product of GO-PEG-folate."
    }, {
      "heading" : "2.3 Generation of 1O2 phosphorescence",
      "text" : "For 1O2 sensitization experiments, GO-PEG-folate suspension in D2O was placed in a cuvette in the spectrometer (FLS920, Edinburgh, 450 W broadband Xe lamp). To cut-off both the scattering and stray light having wavelengths shorter than 1000 nm, a 1000 nm longpass filter (Iszu Optics, LP1000) was placed in-between the sample and the detector."
    }, {
      "heading" : "2.4 DPBF quenching experiment",
      "text" : "0.08 mM DPBF (1,3-diphenyl isobenzofuran) and 0.5 mg/mL GO-PEG-folate were thoroughly mixed and irradiated with a 980 nm (1 W/cm2) laser for 14 min. The absorbance of the solution at 410 nm was measured for every 2 min using a Uv-visible spectrophotometer. The decrease in the absorbance of DPBF caused by the photobleaching was measured in all experiments.\n2.5 In vitro cellular uptake experiments\nB16F0 cells were cultured and treated with various concentrations of GO-PEG-folate for 4 h. The cells were washed with PBS and fixed onto a glass slide using 4%-paraformaldehyde\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n5\nfor 5 min, followed by washing with PBST (5% Tween-20 in PBS) twice. The cells were immediately stained with DAPI (4′,6-diamidino-2- phenylindole) and visualized under a confocal microscope (Leica, TCS SP5X)."
    }, {
      "heading" : "2.6 Cytotoxicity assays",
      "text" : "B16F0 cells were cultured and various concentrations of GO-PEG-folate were added and incubated in dark at 37 oC for 1 day. The photo-induced cellular deaths were estimated by irradiating the GO-PEG-folate internalized B16F0 cells with 808 nm (320 mW/cm2; 15 min) and 980 nm (320 mW/cm2; 18 min) CW lasers. The irradiation times for the two wavelengths were adjusted by considering the absorbance values of GO-PEG-folate at 980 and 808 nm, so that the numbers of absorbed photons at both wavelengths are the same. The cells were incubated for another 12 h and 50 µL of MTT reagent (0.5 mg/mL) was added and incubated for another 4 h. Finally, DMSO was added to lyse the cell membrane and then centrifuged at 13000 rpm. The supernatant was collected and analyzed in the microplate reader at 570 nm."
    }, {
      "heading" : "2.7 In vitro detection of reactive oxygen species (ROS) experiments",
      "text" : "The B16F0 cells were cultured and various concentrations of GO-PEG-folate were added\nand uptaken for 4 h. The cells were then then subjected to photo-irradiation with 808 and 980 nm lasers. The cell culture medium was replaced with 5 µM of 2, 7-dichlorofluorescien diacetate (DCFH-DA) and incubated for 30 min at 37 oC. The cells were then trypsinized and suspended in 1 mL PBS and subjected to flow cytometric analysis. For ROS scavenging experiments, B16F0 cells were pretreated with 50 mM NaN3 solution and incubated for 1 h, which was followed by photo-irradiation and flow cytometric analysis."
    }, {
      "heading" : "2.8 Intracellular detection of 1O2 using singlet oxygen sensor green (SOSG)",
      "text" : "The B16F0 cells were cultured and various concentrations of GO-PEG-folate were added\nand uptaken for 4 h. 2 µL of SOSG (Invitrogen, USA) was added and incubated for 30 min. The cells were then photo irradiated, followed by flow cytometry analysis.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n6"
    }, {
      "heading" : "2.9 Intracellular detection of heat-shock protein (HSP70) expression levels",
      "text" : "The B16F0 cells were cultured and various concentrations of GO-PEG-folate were added and uptaken for 4 h. The GO-PEG-folate internalized cells were photo-irradiated followed by staining with the Alexa Fluor 488 conjugated HSP 70 antibodies (1:20 dilution; BioLegend, USA) and subjected to flow cytometry analysis."
    }, {
      "heading" : "2.10 In vivo tumor growth study using GO-PEG-folate",
      "text" : "The mice (C57BL/6J male purchased from National Laboratory Animal Center, Taiwan) were feeded and raised according to the Institutional Animal Care and Use Committee (IACUC) protocol. B16F0 melanoma cells were implanted subcutaneously into the leg muscle region of each mouse. The in vivo experiments were started when their tumor diameters reached ~2 mm. Eight groups of mice were used for the experiments, in which two groups of PBS injected group (120 µL/mice) and another with GO-PEG-folate injected group (200 µL/mice; 8 mg/kg) were left without photo-irradiation and another 4 groups were exposed with 808 nm (250 mW/cm2; 8 min) and 980 nm (250 mW/cm2; 10 min) CW lasers every day. The intravenous injection was performed for two times during the course of the therapy. In addition, one group was kept as blank control and another group was injected with doxorubicin. The tumor volumes were measured every day. The inter-tumoral temperature was monitored using a Thermo shot F30 camera. 2.11 In vivo fluorescence imaging using GO-PEG-folate\nFor in vivo fluorescence imaging experiments, both PBS (200 µL/mice) and GO-PEG-folate aqueous dispersion (200 µL/mice; 8 mg/kg) were intravenously injected into the B16F0 tumor bearing mice. After 24 h post-injection, isoflurane was passed for 5 min, so that the mice can get anaesthetized, and then placed into the IVIS Xenogen chamber. The fluorescence images were recorded using 570 nm/640 nm excitation/emission set of filters with an exposure time of 60 s.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n7"
    }, {
      "heading" : "3. Results and Discussion",
      "text" : ""
    }, {
      "heading" : "3.1. Synthesis and characterization of GO and GO-PEG-folate",
      "text" : "GO was prepared from graphite flakes by using the literature reported Hummer’s process [34,35]. The as-synthesized GO nanosheets were further functionalized with NH2-PEGfolate moiety via EDC coupling to form GO-PEG-folate to ensure the targeting ability of the folate moieties to the folate receptors on cancer cells (see Figure 1). The atomic force microscopy (AFM) image in Figure S1 (a) clearly exhibits the layered structure of nanosizedGO. The dynamic light scattering (DLS) analysis and transmission electron microscopy (TEM) image of GO-PEG-folate dispersion clearly exhibits an average particle size of ~100 nm (see Figure S1 (b) and Figure S2). The structure of GO-PEG-folate was examined by using Raman spectrum, in which there are two distinct bands, D and G at 1329 and 1606 cm-1, respectively (Figure S3). The successful functionalization of GO-PEG-folate was confirmed by the FT-IR analysis (see Figure S4). The FT-IR spectra of GO shows peaks at 1730 cm-1 (vibrational C=O stretching frequency of surface carboxylic groups), 1620 cm-1 (the skeletal vibrations of C=C), and 1400~1000 cm-1 (the C-O stretching and O-H deformations of the hydroxyl and epoxy groups). Upon successful functionalization of GO with NH2-PEG-folate, the amide bond C=O stretching frequency has appeared at 1632 cm-1, as well as N-H stretching peak at 2900 cm-1, respectively. The UV-vis-NIR absorption spectrum of GOPEG-folate in Figure 2(a) exhibits a broad range of absorption covering until 1100 nm (see solid lines in Figure 2(a)). However, the characteristic peak of GO at 234 nm was shifted to 277 nm for GO-PEG-folate, which also confirms the successful functionalization of NH2PEG-folate molecules on the surface of GO (see Figure S5). In addition, we also observed that GO-PEG-folate can induce generation of singlet O2 upon NIR light excitation. The excitation spectrum for phosphorescence emission of 1O2 reveals five peaks located at 825, 875, 944, 987 and 1007 nm, respectively. Upon excitation using 980 nm light, a singlet O2 phosphorescence emission at ~1265 nm was detected, whereas no any singlet O2\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n8\nphosphorescence signal was detected using 808 nm light excitation (see Figure 2(b)). The singlet O2 phosphorescence quantum yield of GO-PEG-folate at 980 nm is 0.23 (see supplementary information for details). The generation of singlet O2 by the photo-excitation of GO-PEG-folate was also confirmed by1, 3-diphenylisobenzofuran (DPBF) quenching studies [36]. From Figure S6, the result clearly shows that the optical absorbance of DPBF at 410 nm decay continuously upon 980 nm laser irradiation of the solution in the presence of GO-PEG-folate, whereas, in the absence of GO-PEG-folate, DPBF solution does not exhibit any noticeable decay in the absorbance. The photothermal temperature elevation measurements for the aqueous solution of GO-PEG-folate upon photo excitation using 808 nm and 980 nm lights clearly exhibit a change in temperature (∆T) values of 18 oC and 11 oC, respectively. Their photothermal efficiencies (η) are 38.3% and 23.4%, respectively (see supporting information for the details on the photothermal efficiency calculations as well as Figure S7). Taken altogether, direct observation of singlet O2 phosphorescence emission and indirect method for quenching of DPBF-singlet O2 endoperoxide product points to the same conclusion of indispensable singlet O2 sensitization from GO-PEG-folate upon NIR light excitation. Therefore, we anticipate that GO-PEG-folate has a great potential to serve as excellent intrinsic NIR light activatable singlet O2 photosensitizers to exert nanomaterialmediated photodynamic therapeutic (NmPDT) effects, in addition to the literature reported nanomaterial-mediated photothermal therapeutic effects (NmPTT) on killing cancer cells and solid tumors."
    }, {
      "heading" : "3.2. GO-PEG-folate as intrinsic in vitro fluorescent cellular marker",
      "text" : "In the literature, it was demonstrated that graphene oxide can exhibit two-photon excitation induced luminescence and can act as an in vitro fluorescent marker upon photoexcitation by a femto-second laser [37,38]. However, the requirement of expensive femto-second laser set up and the usage of very high laser power intensities (~70 W/cm2) can severely limit the practical\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n9\napplications and feasibility for live cellular/animal imaging [37]. In the present work, we demonstrate that GO-PEG-folate can act as a single-photon excitation induced in vitro fluorescent cellular marker. Furthermore, we also show that the photoluminescence profile of GO-PEG-folate is strongly dependent on the excitation wavelengths (488 nm and 533 nm) used (see Figure 3(a)). The fluorescence emission quantum yields of GO-PEG-folate upon excitation using 488 nm and 533 nm lights are 0.0001 and 0.0003, respectively (see details for the calculations in the supplementary information). The excitation spectra for the singlephoton excited luminescence at 551 and 601 nm wavelengths clearly reveal a broad excitation band ranging from 475~575 nm (see Figure 3(b)). However, the mechanism for such an excitation wavelength dependent photoluminescence of GO-PEG-folate is still unclear and requires further detailed study. Although the fluorescence emission quantum yields are very low under such ultra-low laser power excitation (the excitation power intensities of 488 nm and 533 nm are ~2 mW/cm2), common confocal optical microscopes are still sensitive enough to detect the weak fluorescence emitted from nano GO, as visualized in the in vitro cellular experiments. Nevertheless, it was very clear that GO-PEG-folate can serve as an intrinsic in vitro fluorescent markers upon single-photon excitation operated under very low laser power intensities (2~10 mW/cm2). As shown in Figure 3(c), the confocal images of GO-PEG-folate internalized B16F0 melanoma cells by the photoexcitation of 488, and 533 nm light reveals green and red emission, respectively. The emission wavelengths of photo-excited GO-PEGfolate in the in vitro clearly coincide with those acquired in the solution phase (see Figure 3(a)). In general, the nanomaterial-based intrinsic luminescence probes possess several advantages when compared to that of the organic dyes, such as, a) excellent photostabilities, b) ultra-high molecular extinction coefficients, c) appreciable luminescence quantum yields, which can be suitable for imaging applications, and d) longer circulation times for the nanomaterials in the animal blood stream [39]. Overall, the experiments in Figure 3\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n10\nunambiguously demonstrate that GO-PEG-folate can serve as an excellent single-photon excited fluorescence imaging probe operated under low laser doses."
    }, {
      "heading" : "3.3 In vitro NmPDT and NmPTT experiments using GO-PEG-folate",
      "text" : "In addition to the single-photon excitation wavelength dependent photoluminescence, GOPEG-folate can also induce the generation of 1O2 upon NIR light excitation. To evaluate whether GO-PEG-folate can mediate the NmPDT and NmPTT effects on killing the cancer cells upon NIR light excitation, GO-PEG-folate internalized B16F0 melanoma cancer cells were photo-irradiated using 808 and 980 nm lasers, respectively. GO-PEG-folate internalized B16F0 melanoma cancer cells did not have any noticeable cellular deaths in the dark (see Figure 4(a)). However, upon photo irradiation using 808 and 980 nm lasers high percentage of cellular deaths was observed. The percentage of cellular deaths by 980 nm light irradiation is about 1.9 times higher than the cellular deaths observed using 808 nm light (35% vs. 15% cellular viabilities at a concentration of 75 µg/mL). Upon decreasing the incubation temperature from 37 oC to 4 oC, the cellular deaths were decreased substantially for 808 nm laser irradiation (64.5% vs. 28.5% cellular deaths at a concentration of 75 mg/mL), whereas for the 980 nm light irradiation system, only slight suppression (84.5% vs.69.5% cellular deaths at a concentration of 75 mg/mL) was observed (see Figure 4(b)). From the 1O2 phosphorescence excitation spectrum, it was very clear that GO-PEG-folate can sensitize generation of 1O2 only upon 980 nm light, but no 1O2 was generated using 808 nm light (see the dashed lines in Figure 2(a)). Therefore, the cellular deaths originating from the 808 nm light irradiation is most probably due to pure NmPTT, whereas the combination of NmPDT (major) and NmPTT (minor) is the origin leading to the observed cellular deaths upon 980 nm laser irradiation. In general, the apoptosis process can be triggered very effectively only when the intracellular local temperature has passed beyond a threshold value for a certain period of time (for example, > 50 oC for 4~6 min, or 42~45 oC for 15~60 min) [40]. Among 74% total\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n11\ncellular deaths (for 75 µg/mL GO-PEG-folate, 980 nm photoirradiation), 31% cellular deaths originate from NmPTT and 43% cellular deaths was due to NmPDT effect (see Figure S7 (a) and (b)).\nTo find out the origin of the cellular deaths mediated by GO-PEG-folate upon 808 and 980 nm laser irradiations, the intracellular reactive oxygen species (ROS) levels were monitored. The intracellular ROS levels for the cells irradiated with 980 nm light are ~ 2.5 folds higher than the one irradiated using 808 nm light (~1.5 folds) as well as in the dark, respectively (see Figure 4(c)). To precisely determine whether 1O2 is the key reactive oxygen species or not, sodium azide pretreatment was performed [8-12]. The result in Figure 4(d) clearly shows that the ROS levels were drastically suppressed for the cells irradiated with 980 nm light. Therefore, the results shown in Figure 4 clearly point out that the cellular deaths originated upon excitation with 980 nm light are mostly due to GO-PEG-folate-mediated PDT effects. Furthermore, in order to detect the intracellular singlet oxygen levels, GO-PEG-folateinternalized B16F0 melanoma cancer cells were treated with SOSG (singlet oxygen sensor green) before photo-irradiation [8-12]. The chemical reaction of non-fluorescent SOSG with 1O2 is highly selective, and thus becomes highly fluorescent only upon its reaction with the intracellular singlet oxygen. As shown in Figure S8, fluorescence levels of SOSG observed from GO-PEG-folate internalized B16F0 melanoma cancer cells upon 980 nm photo irradiation is significantly higher than those observed in the dark as well as by 808 nm light irradiation. From Figure S9, it is also very clear that the level of HSP 70 wasere detected for the GO-PEG-folate internalized B16F0 cells irradiated with 980 nm light is also higher than that of 808 nm light at 37 oC incubation. However, the HSP 70 level for 980 nm light irradiation was suppressed at low temperature, i.e., 4 oC incubation. Overall, from the in vitro experiments, we can conclude that the combination of GO-mediated PTT and PDT effects is responsible for the effective phototherapeutic destruction of B16F0 melanoma cancer cells upon 980 nm light excitation.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n12"
    }, {
      "heading" : "3.4 In vivo GO-PEG-folate-mediated NmPDT and NmPTT experiments",
      "text" : "In order to determine whether GO-PEG-folate mediated NmPDT and NmPTT effects can achieve effective therapeutic destruction of B16F0 melanoma tumors by using both 808 and 980 nm light, GO-PEG-folate was intravenously injected into the C57BL/6J mice through tail-vein. In addition, the folate moieties can recognize or target at the tumor sites, as it was well-known that most of the melanoma tumors are over-expressed with folate receptors on cellular membrane [41]. After 24 h post intravenous injection, the near-IR luminescence from the internalized GO-PEG-folate was clearly visualized with higher TBR (tumor-tobackground ratio) (see Figure 5(a) & (b)). In addition to the IVIS animal imaging experiments, we have also detected the green and red fluorescence emission from GO-PEGfolate internalized B16F0 melanoma tumor tissue in the confocal laser scanning optical microscope, upon excitation with 488 and 533 nm lights (see Figure S10), indicating that GO-PEG-folate was effectively co-localized at the tumor site. For the phototherapy experiments, two groups of tumor-inoculated C57BL/6J mice were immediately exposed to 808 and 980 nm lasers, respectively. Upon laser irradiation, GO-PEG-folate injected mice exhibited significant temperature elevation with ∆T of 8.8 and 1.8 oC for 808 and 980 nm light irradiation, respectively (see Figures 6(a) ~ (d) for the photothermal images). The overall temperature rise profiles for PBS and GO-PEG-folate injected mice exposed with 808 and 980 nm lasers were shown in Figure 6(e). In Figure 7(a) & (b), the mice treated with GO-PEG-folate and irradiated with 980 nm laser (0.02 of the initial tumor size) showed a very significant tumor destruction at day 14, which is far better than those treated with doxorubicin and 808 nm light irradiation (57.5 and 10.1 of initial tumor sizes). It is also interesting to note that the tumor site of the mice treated with GO-PEG-folate and exposure to 980 nm laser light forms a scar at day 14, which peeled off later, followed by the development of new skin at the irradiation site. In contrast, for the mice exposed to 808 nm laser light, part of tumor region forms scar in companied with large area of tumor re-growth. During the course of therapy, no\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n13\nany noticeable changes in the body weight were observed (see Figure S11). The average half-life span for the mice treated with GO-PEG-folate and exposure to 980 nm laser is longer than 40 days, which is much longer than the mice treated doxorubicin (17 days), or treated with GO-PEG-folate and exposure to 808 nm laser group (34 days), as well as untreated mice group (16 days), respectively (see Figure S12). The caspase-3 expression in tumor tissues obtained from the GO-PEG-folate-internalized and 980 nm light irradiation group induced higher percentage of apoptotic cells as compared to the 808 nm treatment group (see Figure 8(a) and (b)). Hematoxylin & Eosin (HE) staining of liver and spleen tissue sections indicated no damage for both GO-PEG-folate-treated and PBS mice. In the case of GOPEG-folate-treated mice (980 nm); necrosis was very severe (see Figure S13). Overall, NIR light excitation of GO-PEG-folate can generate either singlet O2 or heat (or both), depending on the excitation wavelengths used (808 nm or 980 nm). The singlet O2 and subsequently formed ROS can cause effective damages to the intracellular components and finally leads to apoptosis or necrosis of cancer cells or solid tumors. Our work clearly demonstrated that the successful destruction of malignant tumors can be achieved by GO-PEG-folate-mediated dual modal NmPDT and NmPTT effects."
    }, {
      "heading" : "4. Conclusions",
      "text" : "In summary, we have successfully explored a novel theranostic platform based on graphene oxide for fluorescence imaging and NIR light activatable bimodal photodynamic and photothermal therapeutic destruction of solid tumors. The GO-PEG-folate exhibits singlephoton excitation wavelength dependent photoluminescence operated under very low laser doses (5~10 mW/cm2). In addition, we also demonstrated for the first time that GO-PEGfolate can sensitize the formation of singlet oxygen to exert dual modal in vivo nanomaterialmediated photodynamic (NmPDT) and photothermal therapeutic (NmPTT) destruction of tumors upon NIR light (980 nm) activation without the co-presence of any photosensitizers.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n14\nThe ability to absorb NIR light and to induce the generation of singlet oxygen is a very unique feature of graphene oxide, because NIR light offers deeper tissue penetration depths and provides a feasible alternative for the treatment of deeply seated tumors. In the in vitro experiments, the detection of the intracellular ROS and HSP 70 expression levels confirms that the cellular deaths were mediated via NmPDT and NmPTT pathways. Our in vivo experiments also showed that the combination of NmPDT and NmPTT effects (mediated by GO-PEG-folate) is more effective than the NmPTT effect alone (via 808 nm light irradiation) and anticancer drug, doxorubicin, in the destruction of melanoma tumors. Taken altogether, we have demonstrated that GO-PEG-folate has a great potential to be used clinically as a very good theranostic nanomaterial able to act simultaneously as fluorescent cellular marker as well as dual modal NmPDT and NmPTT reagent for effective destruction for solid tumors."
    }, {
      "heading" : "Acknowledgements",
      "text" : "The authors are grateful to the financial support from the Ministry of Science and\nTechnology, Taiwan.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n15\nFigure Captions\nTable 1. Brief literature overview of the laser wavelengths, power intensities and irradiation time used in the various carbon nanostructures mediated PTT effects. Figure 1. Schematic representation for the synthesis of GO-PEG-folate to facilitate the combination of nanomaterial-mediated photodynamic and photothermal therapeutic destruction of tumors. Figure 2. (a) UV-visible-NIR absorption spectrum and excitation spectrum for singlet oxygen phosphorescence of GO-PEG-folate (λem= 1265 nm) in D2O. (B) Singlet oxygen phosphorescence emission spectra of GO-PEG-folate at 808 and 980 nm excitation wavelengths, respectively. Figure 3. (a) Single photon excited luminescence profiles of GO-PEG-folate in aqueous solution at 488 nm and 533 nm excitation wavelengths. (b) Excitation profiles of GO-PEGfolate at 551 nm and 601 nm emission wavelengths. (c) Confocal laser scanning microscopic images of photo excited GO-PEG-folate internalized B16F0 melanoma cells by 488 and 533 nm light. The fluorescence was monitored from green and red channels, respectively. The B16F0 melanoma cell nucleus was stained with DAPI dye with an excitation at 404 nm. Figure 4. Cell viabilities of B16F0 cells internalized with GO-PEG-folate and treated in the dark and under photo irradiation conditions (808 and 980 nm) at (a) 37 oC and (b) 4 oC. (c) and (d) represents the ROS levels monitored by DCF fluorescence using flow cytometry for B16F0 cells internalized with GO-PEG-folate, followed by photo irradiation with and without NaN3 pretreatment at 37 oC, respectively. Figure 5. In vivo fluorescence imaging of GO-PEG-folate. (a) NIR fluorescence images from PBS (left) and GO-PEG-folate (right) mice at 24 h after intravenous injection. (b) Tumor-tobackground ratio (TBR) integrated from the NIR fluorescence images for both PBS and GOPEG-folate, respectively. Figure 6. (a) ~ (d) Photothermal images of mice under different conditions as labeled in the figures. (e) Temperature rise profiles as a function of irradiation time for conditions (a) ~ (d). The dashed blue lines indicated the time points where the lasers were turned off. Figure 7. (a) Relative tumor volumes in different treatment groups as a function of number of days after irradiation. (b) The representative mice images showing the sizes of tumors\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n16\n(highlighted by dashed white circles) at day 1 and day 15 under 808 and 980 nm photo irradiation conditions, respectively. Figure 8. (a) Caspase-3 activity in tumor tissue dissected from the mice with different treatment groups immediately after phototherapy. The nucleus of the tissue is stained with DAPI. (b) The apoptotic index represented as the mean fluorescence intensities of caspase-3 after quantifying the whole tumor tissue area for the mice treated with PBS as well as GOPEG-folate and exposed to 808 and 980 nm lights, respectively.\nM AN\nUS CR\nIP T\nAC CE\nPT\nED\n18\nFigure 1. Schematic representation for the synthesis of GO-PEG-folate to facilitate the combination of nanomaterial-mediated photodynamic and photothermal therapeutic destruction of tumors.\nM AN\nUS CR\nIP T\nAC CE\nPT\nED\n19\nFigure 2. (a) UV-visible-NIR absorption spectrum and excitation spectrum for singlet oxygen phosphorescence of GO-PEG-folate (λem= 1265 nm) in D2O. (B) Singlet oxygen phosphorescence emission spectra of GO-PEG-folate at 808 and 980 nm excitation wavelengths, respectively.\nM\nAN\nUS CR\nIP T\nAC CE\nPT ED\n20\nFigure 3. (a) Single photon excited luminescence profiles of GO-PEG-folate in aqueous solution at 488 nm and 533 nm excitation wavelengths. (b) Excitation profiles of GO-PEGfolate at 551 nm and 601 nm emission wavelengths. (c) Confocal laser scanning microscopic images of photo excited GO-PEG-folate internalized in B16F0 melanoma cells (λex= 488 and 533 nm light). The fluorescence was monitored from green and red channels, respectively. The B16F0 melanoma cell nucleus was stained with DAPI dye, which shows blue emission upon 404 nm excitation.\nAC\nCE\nPT ED\n21\nM AN\nUS\nCR\nIP T\nM AN\nUS CR\nIP T\nAC\nCE\nPT\nED\n23\nFigure 6. (a) ~ (d) Photothermal images of mice under different conditions as labeled in the figures. (e) Temperature rise profiles as a function of irradiation time for conditions (a) ~ (d). The dashed blue lines indicated the time points where the lasers were turned off.\nM AN\nUS\nCR\nIP T\nAC CE\nPT ED\n24\nFigure 7. (a) Relative tumor volumes in different treatment groups as a function of number of days after irradiation. (b) The representative mice images showing the sizes of tumors (highlighted by dashed white circles) at day 1 and day 15 under 808 and 980 nm photo irradiation conditions, respectively.\nM AN\nUS\nCR\nIP T\nAC CE\nPT\nED\n25\nFigure 8. (a) Caspase-3 activity in tumor tissue dissected from the mice with different treatment groups immediately after phototherapy. The nucleus of the tissue is stained with DAPI. (b) The apoptotic index represented as the mean fluorescence intensities of caspase-3 after quantifying the whole tumor tissue area for the mice treated with PBS as well as GOPEG-folate and exposed to 808 and 980 nm lights, respectively.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n[1] Jemal A, Center MM, DeSantis C, Ward EM. Global Patterns of Cancer Incidence and\nMortality Rates and Trends. Cancer Epidemiology Biomarkers & Prevention. 2010;19:1893-907. [2] Dolmans DEJGJ, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev\nCancer. 2003;3:380-7.\n[3] Huang Z, Xu H, Meyers AD, Musani AI, Wang L, Tagg R, et al. Photodynamic Therapy\nfor Treatment of Solid Tumors — Potential and Technical Challenges. Technology in Cancer Research & Treatment. 2008;7:309-20. [4] Lucky SS, Soo KC, Zhang Y. Nanoparticles in Photodynamic Therapy. Chemical\nReviews. 2015;115:1990-2042.\n[5] Samia ACS, Chen X, Burda C. Semiconductor Quantum Dots for Photodynamic\nTherapy. Journal of the American Chemical Society. 2003;125:15736-7.\n[6] Konovalova TA, Lawrence J, Kispert LD. Generation of superoxide anion and most\nlikely singlet oxygen in irradiated TiO2 nanoparticles modified by carotenoids. Journal of Photochemistry and Photobiology A: Chemistry. 2004;162:1-8. [7] Prat F, Marti C, Nonell S, Zhang X, Foote CS, Moreno RG, et al. C60 Fullerene-based\nmaterials as singlet oxygen O2(1[capital Delta]g) photosensitizers: a time-resolved nearIR luminescence and optoacoustic study. Physical Chemistry Chemical Physics. 2001;3:1638-43. [8] Vankayala R, Huang Y-K, Kalluru P, Chiang C-S, Hwang KC. First Demonstration of\nGold Nanorods-Mediated Photodynamic Therapeutic Destruction of Tumors via Near Infra-Red Light Activation. Small. 2014;10:1612-22.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n[9] Vankayala R, Lin C-C, Kalluru P, Chiang C-S, Hwang KC. Gold nanoshells-mediated\nbimodal photodynamic and photothermal cancer treatment using ultra-low doses of near infra-red light. Biomaterials. 2014;35:5527-38. [10] Vijayaraghavan P, Liu C-H, Vankayala R, Chiang C-S, Hwang KC. Designing\nMulti-Branched Gold Nanoechinus for NIR Light Activated Dual Modal Photodynamic and Photothermal Therapy in the Second Biological Window. Advanced Materials. 2014;26:6689-95. [11] Vijayaraghavan P, Vankayala R, Chiang C-S, Sung H-W, Hwang KC. Complete\ndestruction of deep-tissue buried tumors via combination of gene silencing and gold nanoechinus-mediated photodynamic therapy. Biomaterials. 2015;62:13-23. [12] Kalluru P, Vankayala R, Chiang C-S, Hwang KC. Photosensitization of Singlet\nOxygen and In Vivo Photodynamic Therapeutic Effects Mediated by PEGylated W18O49 Nanowires. Angewandte Chemie International Edition. 2013;52:12332-6. [13] Wang S, Riedinger A, Li H, Fu C, Liu H, Li L, et al. Plasmonic Copper Sulfide\nNanocrystals Exhibiting Near-Infrared Photothermal and Photodynamic Therapeutic Effects. ACS Nano. 2015;9:1788-800. [14] Gao L, Liu R, Gao F, Wang Y, Jiang X, Gao X. Plasmon-Mediated Generation of\nReactive Oxygen Species from Near-Infrared Light Excited Gold Nanocages for Photodynamic Therapy in Vitro. ACS Nano. 2014;8:7260-71. [15] Taylor AB, Siddiquee AM, Chon JWM. Below Melting Point Photothermal\nReshaping of Single Gold Nanorods Driven by Surface Diffusion. ACS Nano. 2014;8:12071-9.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n[16] Horiguchi Y, Honda K, Kato Y, Nakashima N, Niidome Y. Photothermal\nReshaping of Gold Nanorods Depends on the Passivating Layers of the Nanorod Surfaces. Langmuir. 2008;24:12026-31. [17] Huang X, El-Sayed MA. Gold nanoparticles: Optical properties and\nimplementations in cancer diagnosis and photothermal therapy. Journal of Advanced Research. 2010;1:13-28. [18] Mombeshora ET, Nyamori VO. A review on the use of carbon nanostructured\nmaterials in electrochemical capacitors. International Journal of Energy Research. 2015;39:1955-80. [19] Smith BR, GhosnEliver Eid B, Rallapalli H, Prescher JA, Larson T, Herzenberg\nLA, et al. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat Nanotech. 2014;9:481-7. [20] Kim H, Namgung R, Singha K, Oh I-K, Kim WJ. Graphene Oxide–\nPolyethylenimine Nanoconstruct as a Gene Delivery Vector and Bioimaging Tool. Bioconjugate Chemistry. 2011;22:2558-67. [21] Feng L, Zhang S, Liu Z. Graphene based gene transfection. Nanoscale.\n2011;3:1252-7.\n[22] Robinson JT, Tabakman SM, Liang Y, Wang H, Sanchez Casalongue H, Vinh D,\net al. Ultrasmall Reduced Graphene Oxide with High Near-Infrared Absorbance for Photothermal Therapy. Journal of the American Chemical Society. 2011;133:6825-31. [23] Su S, Wang J, Wei J, Martinez-Zaguilan R, Qiu J, Wang S. Efficient\nphotothermal therapy of brain cancer through porphyrin functionalized graphene oxide. New Journal of Chemistry. 2015;39:5743-9.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n[24] Li J-L, Hou X-L, Bao H-C, Sun L, Tang B, Wang J-F, et al. Graphene oxide\nnanoparticles for enhanced photothermal cancer cell therapy under the irradiation of a femtosecond laser beam. Journal of Biomedical Materials Research Part A. 2014;102:2181-8. [25] Burke A, Ding X, Singh R, Kraft RA, Levi-Polyachenko N, Rylander MN, et al.\nLong-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proceedings of the National Academy of Sciences. 2009;106:12897-902. [26] American National Standards Institute. American National Standard for safe use\nof lasers. Orlando (Fla): Laser Institute of America, 2000.\n[27] Kam NWS, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as\nmultifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:11600-5. [28] Yang K, Zhang S, Zhang G, Sun X, Lee S-T, Liu Z. Graphene in Mice: Ultrahigh\nIn Vivo Tumor Uptake and Efficient Photothermal Therapy. Nano Letters. 2010;10:3318- 23. [29] Su S, Wang J, Wei J, Martinez-Zaguilan R, Qiu J, Wang S. Efficient\nphotothermal therapy of brain cancer through porphyrin functionalized graphene oxide. New Journal of Chemistry. 2015;39:5743-9. [30] Akhavan O, Ghaderi E, Aghayee S, Fereydooni Y, Talebi A. The use of a\nglucose-reduced graphene oxide suspension for photothermal cancer therapy. Journal of Materials Chemistry. 2012;22:13773-81.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n[31] Akhavan O, Ghaderi E, Emamy H. Nontoxic concentrations of PEGylated\ngraphene nanoribbons for selective cancer cell imaging and photothermal therapy. Journal of Materials Chemistry. 2012;22:20626-33. [32] Murakami T, Nakatsuji H, Inada M, Matoba Y, Umeyama T, Tsujimoto M, et al.\nPhotodynamic and Photothermal Effects of Semiconducting and Metallic-Enriched Single-Walled Carbon Nanotubes. Journal of the American Chemical Society. 2012;134:17862-5. [33] Ge J, Lan M, Zhou B, Liu W, Guo L, Wang H, et al. A graphene quantum dot\nphotodynamic therapy agent with high singlet oxygen generation. Nat Commun. 2014;5:4596 | DOI: 10.1038. [34] Markovic ZM, Ristic BZ, Arsikin KM, Klisic DG, Harhaji-Trajkovic LM,\nTodorovic-Markovic BM, et al. Graphene quantum dots as autophagy-inducing photodynamic agents. Biomaterials. 2012; 33:7084-92. [35] Hummers WS, Offeman RE. Preparation of Graphitic Oxide. Journal of the\nAmerican Chemical Society. 1958;80:1339.\n[36] Marcano DC, Kosynkin DV, Berlin JM, Sinitskii A, Sun Z, Slesarev A, et al.\nImproved Synthesis of Graphene Oxide. ACS Nano. 2010;4:4806-14.\n[37] Vankayala R, Kuo C-L, Sagadevan A, Chen P-H, Chiang C-S, Hwang KC.\nMorphology dependent photosensitization and formation of singlet oxygen (1[capital Delta]g) by gold and silver nanoparticles and its application in cancer treatment. Journal of Materials Chemistry B. 2013;1:4379-87.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\n[38] Li J-L, Bao H-C, Hou X-L, Sun L, Wang X-G, Gu M. Graphene Oxide\nNanoparticles as a Nonbleaching Optical Probe for Two-Photon Luminescence Imaging and Cell Therapy. Angewandte Chemie International Edition. 2012;51:1830-4. [39] Pramanik A, Chavva SR, Fan Z, Sinha SS, Nellore BPV, Ray PC. Extremely\nHigh Two-Photon Absorbing Graphene Oxide for Imaging of Tumor Cells in the Second Biological Window. The Journal of Physical Chemistry Letters. 2014;5:2150-4. [40] Singh SK. Red and near infrared persistent luminescence nano-probes for\nbioimaging and targeting applications. RSC Advances. 2014;4:58674-98.\n[41] Habash RWY, Bansal R, Krewski D, Alhafid HT. Thermal Therapy, Part 1: An\nIntroduction to Thermal Therapy. 2006;34:459-89.\n[42] Kelemen LE. The role of folate receptor α in cancer development, progression\nand treatment: Cause, consequence or innocent bystander? International Journal of Cancer. 2006;119:243-50."
    } ],
    "references" : [ {
      "title" : "Global Patterns of Cancer Incidence and Mortality Rates and Trends",
      "author" : [ "A Jemal", "MM Center", "C DeSantis", "EM. Ward" ],
      "venue" : "Cancer Epidemiology Biomarkers & Prevention",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2010
    }, {
      "title" : "Photodynamic therapy for cancer",
      "author" : [ "Dolmans DEJGJ", "Fukumura D", "Jain RK" ],
      "venue" : "Nat Rev Cancer",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2003
    }, {
      "title" : "Photodynamic Therapy for Treatment of Solid Tumors — Potential and Technical Challenges",
      "author" : [ "Z Huang", "H Xu", "AD Meyers", "AI Musani", "L Wang", "R Tagg" ],
      "venue" : "Technology in Cancer Research & Treatment",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2008
    }, {
      "title" : "Nanoparticles in Photodynamic Therapy",
      "author" : [ "SS Lucky", "KC Soo", "Y. Zhang" ],
      "venue" : "Chemical Reviews",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2015
    }, {
      "title" : "Semiconductor Quantum Dots for Photodynamic Therapy",
      "author" : [ "ACS Samia", "X Chen", "C. Burda" ],
      "venue" : "Journal of the American Chemical Society",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2003
    }, {
      "title" : "Generation of superoxide anion and most likely singlet oxygen in irradiated TiO2 nanoparticles modified by carotenoids",
      "author" : [ "TA Konovalova", "J Lawrence", "LD. Kispert" ],
      "venue" : "Journal of Photochemistry and Photobiology A: Chemistry",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2004
    }, {
      "title" : "C60 Fullerene-based materials as singlet oxygen O2(1[capital Delta]g) photosensitizers: a time-resolved near- IR luminescence and optoacoustic study",
      "author" : [ "F Prat", "C Marti", "S Nonell", "X Zhang", "CS Foote", "RG Moreno" ],
      "venue" : "Physical Chemistry Chemical Physics",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2001
    }, {
      "title" : "First Demonstration of Gold Nanorods-Mediated Photodynamic Therapeutic Destruction of Tumors via Near Infra-Red Light Activation",
      "author" : [ "Vankayala R", "Huang Y-K", "Kalluru P", "Chiang C-S", "Hwang KC" ],
      "venue" : "M  AN US CR IP T AC CE PT  ED  ACCEPTED MANUSCRIPT",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2014
    }, {
      "title" : "Gold nanoshells-mediated bimodal photodynamic and photothermal cancer treatment using ultra-low doses of near infra-red light",
      "author" : [ "Vankayala R", "Lin C-C", "Kalluru P", "Chiang C-S", "Hwang KC" ],
      "venue" : null,
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2014
    }, {
      "title" : "Designing Multi-Branched Gold Nanoechinus for NIR Light Activated Dual Modal Photodynamic and Photothermal Therapy in the Second Biological Window",
      "author" : [ "Vijayaraghavan P", "Liu C-H", "Vankayala R", "Chiang C-S", "Hwang KC" ],
      "venue" : "Advanced Materials",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2014
    }, {
      "title" : "Complete destruction of deep-tissue buried tumors via combination of gene silencing and gold nanoechinus-mediated photodynamic therapy",
      "author" : [ "Vijayaraghavan P", "Vankayala R", "Chiang C-S", "Sung H-W", "Hwang KC" ],
      "venue" : null,
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2015
    }, {
      "title" : "Photosensitization of Singlet Oxygen and In Vivo Photodynamic Therapeutic Effects Mediated by PEGylated W18O49 Nanowires",
      "author" : [ "Kalluru P", "Vankayala R", "Chiang C-S", "Hwang KC" ],
      "venue" : "Angewandte Chemie International Edition",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2013
    }, {
      "title" : "Plasmonic Copper Sulfide Nanocrystals Exhibiting Near-Infrared Photothermal and Photodynamic Therapeutic Effects",
      "author" : [ "S Wang", "A Riedinger", "H Li", "C Fu", "H Liu", "L Li" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2015
    }, {
      "title" : "Plasmon-Mediated Generation of Reactive Oxygen Species from Near-Infrared Light Excited Gold Nanocages for Photodynamic Therapy in Vitro",
      "author" : [ "L Gao", "R Liu", "F Gao", "Y Wang", "X Jiang", "X. Gao" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2014
    }, {
      "title" : "Below Melting Point Photothermal Reshaping of Single Gold Nanorods Driven by Surface Diffusion",
      "author" : [ "AB Taylor", "AM Siddiquee", "JWM. Chon" ],
      "venue" : "ACS Nano. 2014;8:12071-9",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2071
    }, {
      "title" : "Photothermal Reshaping of Gold Nanorods",
      "author" : [ "Y Horiguchi", "K Honda", "Y Kato", "N Nakashima", "Y. Niidome" ],
      "venue" : "Depends on the Passivating Layers of the Nanorod Surfaces. Langmuir",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2026
    }, {
      "title" : "Gold nanoparticles: Optical properties and implementations in cancer diagnosis and photothermal therapy",
      "author" : [ "Huang X", "El-Sayed MA" ],
      "venue" : "Journal of Advanced Research",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2010
    }, {
      "title" : "A review on the use of carbon nanostructured materials in electrochemical capacitors",
      "author" : [ "Mombeshora ET", "Nyamori VO" ],
      "venue" : "International Journal of Energy Research",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 1955
    }, {
      "title" : "Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour",
      "author" : [ "BR Smith", "B GhosnEliver Eid", "H Rallapalli", "JA Prescher", "T Larson", "LA Herzenberg" ],
      "venue" : null,
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2014
    }, {
      "title" : "Graphene Oxide– Polyethylenimine Nanoconstruct as a Gene Delivery Vector and Bioimaging Tool",
      "author" : [ "H Kim", "R Namgung", "K Singha", "I-K Oh", "WJ. Kim" ],
      "venue" : "Bioconjugate Chemistry",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2011
    }, {
      "title" : "Graphene based gene transfection",
      "author" : [ "L Feng", "S Zhang", "Z. Liu" ],
      "venue" : null,
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2011
    }, {
      "title" : "Ultrasmall Reduced Graphene Oxide with High Near-Infrared Absorbance for Photothermal Therapy",
      "author" : [ "JT Robinson", "SM Tabakman", "Y Liang", "H Wang", "H Sanchez Casalongue", "D Vinh" ],
      "venue" : "Journal of the American Chemical Society",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2011
    }, {
      "title" : "Efficient photothermal therapy of brain cancer through porphyrin functionalized graphene oxide",
      "author" : [ "S Su", "J Wang", "J Wei", "R Martinez-Zaguilan", "J Qiu", "S. Wang" ],
      "venue" : "New Journal of Chemistry",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2015
    }, {
      "title" : "Graphene oxide nanoparticles for enhanced photothermal cancer cell therapy under the irradiation of a femtosecond laser beam",
      "author" : [ "Li J-L", "Hou X-L", "Bao H-C", "Sun L", "Tang B", "Wang J-F" ],
      "venue" : "Journal of Biomedical Materials Research Part A",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2014
    }, {
      "title" : "Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation",
      "author" : [ "A Burke", "X Ding", "R Singh", "RA Kraft", "N Levi-Polyachenko", "MN Rylander" ],
      "venue" : "Proceedings of the National Academy of Sciences",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2009
    }, {
      "title" : "Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction",
      "author" : [ "NWS Kam", "M O'Connell", "JA Wisdom", "H. Dai" ],
      "venue" : "Proceedings of the National Academy of Sciences of the United States of America",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2005
    }, {
      "title" : "Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal Therapy",
      "author" : [ "K Yang", "S Zhang", "G Zhang", "X Sun", "S-T Lee", "Z. Liu" ],
      "venue" : "Nano Letters",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2010
    }, {
      "title" : "Efficient photothermal therapy of brain cancer through porphyrin functionalized graphene oxide",
      "author" : [ "S Su", "J Wang", "J Wei", "R Martinez-Zaguilan", "J Qiu", "S. Wang" ],
      "venue" : "New Journal of Chemistry",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2015
    }, {
      "title" : "The use of a glucose-reduced graphene oxide suspension for photothermal cancer therapy",
      "author" : [ "O Akhavan", "E Ghaderi", "S Aghayee", "Y Fereydooni", "A. Talebi" ],
      "venue" : "Journal of Materials Chemistry",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2012
    }, {
      "title" : "Nontoxic concentrations of PEGylated graphene nanoribbons for selective cancer cell imaging and photothermal therapy",
      "author" : [ "O Akhavan", "E Ghaderi", "H. Emamy" ],
      "venue" : "Journal of Materials Chemistry",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2062
    }, {
      "title" : "Photodynamic and Photothermal Effects of Semiconducting and Metallic-Enriched Single-Walled Carbon Nanotubes",
      "author" : [ "T Murakami", "H Nakatsuji", "M Inada", "Y Matoba", "T Umeyama", "M Tsujimoto" ],
      "venue" : "Journal of the American Chemical Society",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2012
    }, {
      "title" : "A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation",
      "author" : [ "J Ge", "M Lan", "B Zhou", "W Liu", "L Guo", "H Wang" ],
      "venue" : "Nat Commun",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2014
    }, {
      "title" : "Graphene quantum dots as autophagy-inducing photodynamic agents",
      "author" : [ "ZM Markovic", "BZ Ristic", "KM Arsikin", "DG Klisic", "LM Harhaji-Trajkovic", "BM Todorovic-Markovic" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2012
    }, {
      "title" : "Preparation of Graphitic Oxide",
      "author" : [ "Hummers WS", "Offeman RE" ],
      "venue" : "Journal of the American Chemical Society",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 1958
    }, {
      "title" : "Improved Synthesis of Graphene Oxide",
      "author" : [ "DC Marcano", "DV Kosynkin", "JM Berlin", "A Sinitskii", "Z Sun", "A Slesarev" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2010
    }, {
      "title" : "Morphology dependent photosensitization and formation of singlet oxygen (1[capital Delta]g) by gold and silver nanoparticles and its application in cancer treatment",
      "author" : [ "Vankayala R", "Kuo C-L", "Sagadevan A", "Chen P-H", "Chiang C-S", "Hwang KC" ],
      "venue" : "Journal of Materials Chemistry B. 2013;1:4379-87",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2013
    }, {
      "title" : "Graphene Oxide Nanoparticles as a Nonbleaching Optical Probe for Two-Photon Luminescence Imaging and Cell Therapy",
      "author" : [ "Li J-L", "Bao H-C", "Hou X-L", "Sun L", "Wang X-G", "Gu M" ],
      "venue" : "Angewandte Chemie International Edition",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2012
    }, {
      "title" : "Extremely High Two-Photon Absorbing Graphene Oxide for Imaging of Tumor Cells in the Second Biological Window",
      "author" : [ "A Pramanik", "SR Chavva", "Z Fan", "SS Sinha", "BPV Nellore", "PC. Ray" ],
      "venue" : "The Journal of Physical Chemistry Letters",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2014
    }, {
      "title" : "Red and near infrared persistent luminescence nano-probes for bioimaging and targeting applications",
      "author" : [ "Singh SK" ],
      "venue" : "RSC Advances",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2014
    }, {
      "title" : "Thermal Therapy, Part 1: An Introduction to Thermal Therapy",
      "author" : [ "RWY Habash", "R Bansal", "D Krewski", "HT. Alhafid" ],
      "venue" : null,
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2006
    }, {
      "title" : "The role of folate receptor α in cancer development, progression and treatment: Cause, consequence or innocent bystander",
      "author" : [ "Kelemen LE" ],
      "venue" : "International Journal of Cancer",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2006
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Introduction Cancer is one of the death-leading diseases for human beings, accounting for ~15% of the total human deaths [1].",
      "startOffset" : 121,
      "endOffset" : 124
    }, {
      "referenceID" : 1,
      "context" : "Among various cancer therapeutic treatment technologies, photodynamic therapy (PDT) is emerging, owing to its non-invasiveness, reduced side-effects, circumventing multiple drug-resistance problems, causing less damage to non-cancerous tissues and low systemic cytotoxicity [2].",
      "startOffset" : 274,
      "endOffset" : 277
    }, {
      "referenceID" : 1,
      "context" : "In PDT, the malignant cells are selectively killed by the intracellular reactive oxygen species (ROS), such as, singlet oxygen ((1)O2), produced by the photosensitizers (PS) in the presence of molecular oxygen and light [2,3].",
      "startOffset" : 220,
      "endOffset" : 225
    }, {
      "referenceID" : 2,
      "context" : "In PDT, the malignant cells are selectively killed by the intracellular reactive oxygen species (ROS), such as, singlet oxygen ((1)O2), produced by the photosensitizers (PS) in the presence of molecular oxygen and light [2,3].",
      "startOffset" : 220,
      "endOffset" : 225
    }, {
      "referenceID" : 3,
      "context" : "The clinically used organic PS-mediated PDT has many drawbacks, such as poor photostability, poor water dispersibility, low light absorbing capability and inability to be activated by the near infra-red light (NIR; >800 nm), which can facilitate deep tissue penetration [4].",
      "startOffset" : 270,
      "endOffset" : 273
    }, {
      "referenceID" : 3,
      "context" : "In the modern era, the growth and development of nanotechnology provides a hope for the long-lasting challenges in clinical biomedicine [4].",
      "startOffset" : 136,
      "endOffset" : 139
    }, {
      "referenceID" : 4,
      "context" : "However, their acute cytotoxicity effects constituting from the heavy metals (for example, cadmium and selenium) and extremely low singlet oxygen quantum yields severly restricted its use in the real-world clinical applications [5].",
      "startOffset" : 228,
      "endOffset" : 231
    }, {
      "referenceID" : 5,
      "context" : "However, their applicability for the PDT treatments are limited owing to the negligible tissue penetration depths of UV light [6,7].",
      "startOffset" : 126,
      "endOffset" : 131
    }, {
      "referenceID" : 6,
      "context" : "However, their applicability for the PDT treatments are limited owing to the negligible tissue penetration depths of UV light [6,7].",
      "startOffset" : 126,
      "endOffset" : 131
    }, {
      "referenceID" : 7,
      "context" : "Very recently, near infra-red light activatable metal nanostructures, such as, gold nanorods, nanoshells, nanoechnius, tungsten oxide nanowires and copper sulphide (CuS) nanoparticles were reported as nanomaterialmediated photodynamic therapeutic (NmPDT) reagents for the effective destruction of solid tumors [8-14].",
      "startOffset" : 310,
      "endOffset" : 316
    }, {
      "referenceID" : 8,
      "context" : "Very recently, near infra-red light activatable metal nanostructures, such as, gold nanorods, nanoshells, nanoechnius, tungsten oxide nanowires and copper sulphide (CuS) nanoparticles were reported as nanomaterialmediated photodynamic therapeutic (NmPDT) reagents for the effective destruction of solid tumors [8-14].",
      "startOffset" : 310,
      "endOffset" : 316
    }, {
      "referenceID" : 9,
      "context" : "Very recently, near infra-red light activatable metal nanostructures, such as, gold nanorods, nanoshells, nanoechnius, tungsten oxide nanowires and copper sulphide (CuS) nanoparticles were reported as nanomaterialmediated photodynamic therapeutic (NmPDT) reagents for the effective destruction of solid tumors [8-14].",
      "startOffset" : 310,
      "endOffset" : 316
    }, {
      "referenceID" : 10,
      "context" : "Very recently, near infra-red light activatable metal nanostructures, such as, gold nanorods, nanoshells, nanoechnius, tungsten oxide nanowires and copper sulphide (CuS) nanoparticles were reported as nanomaterialmediated photodynamic therapeutic (NmPDT) reagents for the effective destruction of solid tumors [8-14].",
      "startOffset" : 310,
      "endOffset" : 316
    }, {
      "referenceID" : 11,
      "context" : "Very recently, near infra-red light activatable metal nanostructures, such as, gold nanorods, nanoshells, nanoechnius, tungsten oxide nanowires and copper sulphide (CuS) nanoparticles were reported as nanomaterialmediated photodynamic therapeutic (NmPDT) reagents for the effective destruction of solid tumors [8-14].",
      "startOffset" : 310,
      "endOffset" : 316
    }, {
      "referenceID" : 12,
      "context" : "Very recently, near infra-red light activatable metal nanostructures, such as, gold nanorods, nanoshells, nanoechnius, tungsten oxide nanowires and copper sulphide (CuS) nanoparticles were reported as nanomaterialmediated photodynamic therapeutic (NmPDT) reagents for the effective destruction of solid tumors [8-14].",
      "startOffset" : 310,
      "endOffset" : 316
    }, {
      "referenceID" : 13,
      "context" : "Very recently, near infra-red light activatable metal nanostructures, such as, gold nanorods, nanoshells, nanoechnius, tungsten oxide nanowires and copper sulphide (CuS) nanoparticles were reported as nanomaterialmediated photodynamic therapeutic (NmPDT) reagents for the effective destruction of solid tumors [8-14].",
      "startOffset" : 310,
      "endOffset" : 316
    }, {
      "referenceID" : 14,
      "context" : "2 shift or drop upon laser exposure and hence exhibit significant instability and photothermal reshaping [15,16].",
      "startOffset" : 105,
      "endOffset" : 112
    }, {
      "referenceID" : 15,
      "context" : "2 shift or drop upon laser exposure and hence exhibit significant instability and photothermal reshaping [15,16].",
      "startOffset" : 105,
      "endOffset" : 112
    }, {
      "referenceID" : 16,
      "context" : "In addition, the significant cytotoxicity effects orginated from the cationic surfactants (for example, CTAB) used in the fabrication process and their poor circulation times in the biological bodies can severely limit its applicability in clinical PDT treatments [17].",
      "startOffset" : 264,
      "endOffset" : 268
    }, {
      "referenceID" : 17,
      "context" : "In the recent years, carbon nanostructures have gained significant attention owing to its wide variety of applications in the fields of environmental remediation, energy harvesting, electronics and biomedicine [18].",
      "startOffset" : 210,
      "endOffset" : 214
    }, {
      "referenceID" : 18,
      "context" : "Previously, it was demonstrated that carbon nanostructures, such as, graphene oxide (GO), reduced graphene oxide (rGO) and single- and multi-walled carbon nanotubes (SWCNTs & MWCNTs) can act as nanocarriers to carry DNAs, RNAs and anticancer drugs for the cancer therapeutic treatments [19-21].",
      "startOffset" : 286,
      "endOffset" : 293
    }, {
      "referenceID" : 19,
      "context" : "Previously, it was demonstrated that carbon nanostructures, such as, graphene oxide (GO), reduced graphene oxide (rGO) and single- and multi-walled carbon nanotubes (SWCNTs & MWCNTs) can act as nanocarriers to carry DNAs, RNAs and anticancer drugs for the cancer therapeutic treatments [19-21].",
      "startOffset" : 286,
      "endOffset" : 293
    }, {
      "referenceID" : 20,
      "context" : "Previously, it was demonstrated that carbon nanostructures, such as, graphene oxide (GO), reduced graphene oxide (rGO) and single- and multi-walled carbon nanotubes (SWCNTs & MWCNTs) can act as nanocarriers to carry DNAs, RNAs and anticancer drugs for the cancer therapeutic treatments [19-21].",
      "startOffset" : 286,
      "endOffset" : 293
    }, {
      "referenceID" : 21,
      "context" : "In addition, it was also well documented that these carbon nanostructures can act as nanomaterial-mediated photothermal therapy (NmPTT) reagents upon absorbing the incoming NIR light and converting the photon energy into heat via non-radiative decay transitions for the destruction of cancer cells [22-24].",
      "startOffset" : 298,
      "endOffset" : 305
    }, {
      "referenceID" : 22,
      "context" : "In addition, it was also well documented that these carbon nanostructures can act as nanomaterial-mediated photothermal therapy (NmPTT) reagents upon absorbing the incoming NIR light and converting the photon energy into heat via non-radiative decay transitions for the destruction of cancer cells [22-24].",
      "startOffset" : 298,
      "endOffset" : 305
    }, {
      "referenceID" : 23,
      "context" : "In addition, it was also well documented that these carbon nanostructures can act as nanomaterial-mediated photothermal therapy (NmPTT) reagents upon absorbing the incoming NIR light and converting the photon energy into heat via non-radiative decay transitions for the destruction of cancer cells [22-24].",
      "startOffset" : 298,
      "endOffset" : 305
    }, {
      "referenceID" : 24,
      "context" : "However, using very high laser powers (1 ~ 15 W/cm(2))[25] are practically not feasible for the real time clinical treatments, as the laser powers are far higher than the threshold values for skin tolerance (Maximum Permissible Exposure of skin for 808 and 980 nm wavelengths being 330~350 mW/cm(2) with an exposure time of 10~1000 s) prescribed by ANSI (National Standards Institute) [26].",
      "startOffset" : 54,
      "endOffset" : 58
    }, {
      "referenceID" : 21,
      "context" : "As a brief overview, the laser wavelengths, laser light intensities and irradiation times were summarized for various carbon nanostructures mediated PTT effects reported in the literature (see Table 1) [22,25,27-31].",
      "startOffset" : 202,
      "endOffset" : 215
    }, {
      "referenceID" : 24,
      "context" : "As a brief overview, the laser wavelengths, laser light intensities and irradiation times were summarized for various carbon nanostructures mediated PTT effects reported in the literature (see Table 1) [22,25,27-31].",
      "startOffset" : 202,
      "endOffset" : 215
    }, {
      "referenceID" : 25,
      "context" : "As a brief overview, the laser wavelengths, laser light intensities and irradiation times were summarized for various carbon nanostructures mediated PTT effects reported in the literature (see Table 1) [22,25,27-31].",
      "startOffset" : 202,
      "endOffset" : 215
    }, {
      "referenceID" : 26,
      "context" : "As a brief overview, the laser wavelengths, laser light intensities and irradiation times were summarized for various carbon nanostructures mediated PTT effects reported in the literature (see Table 1) [22,25,27-31].",
      "startOffset" : 202,
      "endOffset" : 215
    }, {
      "referenceID" : 27,
      "context" : "As a brief overview, the laser wavelengths, laser light intensities and irradiation times were summarized for various carbon nanostructures mediated PTT effects reported in the literature (see Table 1) [22,25,27-31].",
      "startOffset" : 202,
      "endOffset" : 215
    }, {
      "referenceID" : 28,
      "context" : "As a brief overview, the laser wavelengths, laser light intensities and irradiation times were summarized for various carbon nanostructures mediated PTT effects reported in the literature (see Table 1) [22,25,27-31].",
      "startOffset" : 202,
      "endOffset" : 215
    }, {
      "referenceID" : 29,
      "context" : "As a brief overview, the laser wavelengths, laser light intensities and irradiation times were summarized for various carbon nanostructures mediated PTT effects reported in the literature (see Table 1) [22,25,27-31].",
      "startOffset" : 202,
      "endOffset" : 215
    }, {
      "referenceID" : 30,
      "context" : "In addition to their intrinsic photothermal properties, it was also reported that semiconducting-SWCNTs can mediate in vitro photodynamic therapeutic effects very efficiently than metallic SWCNTs upon 808 nm light excitation without adding organic photosensitizers [32].",
      "startOffset" : 265,
      "endOffset" : 269
    }, {
      "referenceID" : 31,
      "context" : "3 quantum dots based NmPDT reagent was reported for the highly efficient in vivo cancer therapy activatable using blue light and 660 nm short NIR light [33, 34].",
      "startOffset" : 152,
      "endOffset" : 160
    }, {
      "referenceID" : 32,
      "context" : "3 quantum dots based NmPDT reagent was reported for the highly efficient in vivo cancer therapy activatable using blue light and 660 nm short NIR light [33, 34].",
      "startOffset" : 152,
      "endOffset" : 160
    }, {
      "referenceID" : 31,
      "context" : "3, their structure is still unclear and moreover, their 660 nm short NIR light activation cannot promise the treatment of deep-tissue buried tumors [33].",
      "startOffset" : 148,
      "endOffset" : 152
    }, {
      "referenceID" : 32,
      "context" : "GO was prepared from graphite flakes by using the literature reported Hummer’s process [34,35].",
      "startOffset" : 87,
      "endOffset" : 94
    }, {
      "referenceID" : 33,
      "context" : "GO was prepared from graphite flakes by using the literature reported Hummer’s process [34,35].",
      "startOffset" : 87,
      "endOffset" : 94
    }, {
      "referenceID" : 34,
      "context" : "The generation of singlet O2 by the photo-excitation of GO-PEG-folate was also confirmed by1, 3-diphenylisobenzofuran (DPBF) quenching studies [36].",
      "startOffset" : 143,
      "endOffset" : 147
    }, {
      "referenceID" : 35,
      "context" : "In the literature, it was demonstrated that graphene oxide can exhibit two-photon excitation induced luminescence and can act as an in vitro fluorescent marker upon photoexcitation by a femto-second laser [37,38].",
      "startOffset" : 205,
      "endOffset" : 212
    }, {
      "referenceID" : 36,
      "context" : "In the literature, it was demonstrated that graphene oxide can exhibit two-photon excitation induced luminescence and can act as an in vitro fluorescent marker upon photoexcitation by a femto-second laser [37,38].",
      "startOffset" : 205,
      "endOffset" : 212
    }, {
      "referenceID" : 35,
      "context" : "9 applications and feasibility for live cellular/animal imaging [37].",
      "startOffset" : 64,
      "endOffset" : 68
    }, {
      "referenceID" : 37,
      "context" : "In general, the nanomaterial-based intrinsic luminescence probes possess several advantages when compared to that of the organic dyes, such as, a) excellent photostabilities, b) ultra-high molecular extinction coefficients, c) appreciable luminescence quantum yields, which can be suitable for imaging applications, and d) longer circulation times for the nanomaterials in the animal blood stream [39].",
      "startOffset" : 397,
      "endOffset" : 401
    }, {
      "referenceID" : 38,
      "context" : "In general, the apoptosis process can be triggered very effectively only when the intracellular local temperature has passed beyond a threshold value for a certain period of time (for example, > 50 C for 4~6 min, or 42~45 C for 15~60 min) [40].",
      "startOffset" : 239,
      "endOffset" : 243
    }, {
      "referenceID" : 7,
      "context" : "To precisely determine whether (1)O2 is the key reactive oxygen species or not, sodium azide pretreatment was performed [8-12].",
      "startOffset" : 120,
      "endOffset" : 126
    }, {
      "referenceID" : 8,
      "context" : "To precisely determine whether (1)O2 is the key reactive oxygen species or not, sodium azide pretreatment was performed [8-12].",
      "startOffset" : 120,
      "endOffset" : 126
    }, {
      "referenceID" : 9,
      "context" : "To precisely determine whether (1)O2 is the key reactive oxygen species or not, sodium azide pretreatment was performed [8-12].",
      "startOffset" : 120,
      "endOffset" : 126
    }, {
      "referenceID" : 10,
      "context" : "To precisely determine whether (1)O2 is the key reactive oxygen species or not, sodium azide pretreatment was performed [8-12].",
      "startOffset" : 120,
      "endOffset" : 126
    }, {
      "referenceID" : 11,
      "context" : "To precisely determine whether (1)O2 is the key reactive oxygen species or not, sodium azide pretreatment was performed [8-12].",
      "startOffset" : 120,
      "endOffset" : 126
    }, {
      "referenceID" : 7,
      "context" : "Furthermore, in order to detect the intracellular singlet oxygen levels, GO-PEG-folateinternalized B16F0 melanoma cancer cells were treated with SOSG (singlet oxygen sensor green) before photo-irradiation [8-12].",
      "startOffset" : 205,
      "endOffset" : 211
    }, {
      "referenceID" : 8,
      "context" : "Furthermore, in order to detect the intracellular singlet oxygen levels, GO-PEG-folateinternalized B16F0 melanoma cancer cells were treated with SOSG (singlet oxygen sensor green) before photo-irradiation [8-12].",
      "startOffset" : 205,
      "endOffset" : 211
    }, {
      "referenceID" : 9,
      "context" : "Furthermore, in order to detect the intracellular singlet oxygen levels, GO-PEG-folateinternalized B16F0 melanoma cancer cells were treated with SOSG (singlet oxygen sensor green) before photo-irradiation [8-12].",
      "startOffset" : 205,
      "endOffset" : 211
    }, {
      "referenceID" : 10,
      "context" : "Furthermore, in order to detect the intracellular singlet oxygen levels, GO-PEG-folateinternalized B16F0 melanoma cancer cells were treated with SOSG (singlet oxygen sensor green) before photo-irradiation [8-12].",
      "startOffset" : 205,
      "endOffset" : 211
    }, {
      "referenceID" : 11,
      "context" : "Furthermore, in order to detect the intracellular singlet oxygen levels, GO-PEG-folateinternalized B16F0 melanoma cancer cells were treated with SOSG (singlet oxygen sensor green) before photo-irradiation [8-12].",
      "startOffset" : 205,
      "endOffset" : 211
    }, {
      "referenceID" : 39,
      "context" : "In addition, the folate moieties can recognize or target at the tumor sites, as it was well-known that most of the melanoma tumors are over-expressed with folate receptors on cellular membrane [41].",
      "startOffset" : 193,
      "endOffset" : 197
    }, {
      "referenceID" : 24,
      "context" : "0 W/cm(2) 1 min In vivo (RENCA murine kidney cancer cells) [25]",
      "startOffset" : 59,
      "endOffset" : 63
    }, {
      "referenceID" : 26,
      "context" : "0 W/cm(2) 10 min In vivo (4T1 cells) [28]",
      "startOffset" : 37,
      "endOffset" : 41
    }, {
      "referenceID" : 21,
      "context" : "PEGylated nano-rGO 808 nm 15 W/cm(2) 8 min In vitro (U87MG; human glioma cancer cells) [22]",
      "startOffset" : 87,
      "endOffset" : 91
    }, {
      "referenceID" : 27,
      "context" : "5 W/cm(2) 10 min In vitro (U87MG; human glioma cancer cells) [29]",
      "startOffset" : 61,
      "endOffset" : 65
    }, {
      "referenceID" : 28,
      "context" : "5 W/cm(2) 12 min LNCaP (human prostate cancer cells) [30]",
      "startOffset" : 53,
      "endOffset" : 57
    }, {
      "referenceID" : 29,
      "context" : "5 W/cm(2) 8 min In vitro (U87MG; human glioma cancer cells) [31]",
      "startOffset" : 60,
      "endOffset" : 64
    }, {
      "referenceID" : 0,
      "context" : "[1] Jemal A, Center MM, DeSantis C, Ward EM.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 1,
      "context" : "[2] Dolmans DEJGJ, Fukumura D, Jain RK.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 2,
      "context" : "[3] Huang Z, Xu H, Meyers AD, Musani AI, Wang L, Tagg R, et al.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 5,
      "context" : "[6] Konovalova TA, Lawrence J, Kispert LD.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 6,
      "context" : "[7] Prat F, Marti C, Nonell S, Zhang X, Foote CS, Moreno RG, et al.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 7,
      "context" : "[8] Vankayala R, Huang Y-K, Kalluru P, Chiang C-S, Hwang KC.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 8,
      "context" : "[9] Vankayala R, Lin C-C, Kalluru P, Chiang C-S, Hwang KC.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 9,
      "context" : "[10] Vijayaraghavan P, Liu C-H, Vankayala R, Chiang C-S, Hwang KC.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 10,
      "context" : "[11] Vijayaraghavan P, Vankayala R, Chiang C-S, Sung H-W, Hwang KC.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 11,
      "context" : "[12] Kalluru P, Vankayala R, Chiang C-S, Hwang KC.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 12,
      "context" : "[13] Wang S, Riedinger A, Li H, Fu C, Liu H, Li L, et al.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 13,
      "context" : "[14] Gao L, Liu R, Gao F, Wang Y, Jiang X, Gao X.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 14,
      "context" : "[15] Taylor AB, Siddiquee AM, Chon JWM.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 15,
      "context" : "[16] Horiguchi Y, Honda K, Kato Y, Nakashima N, Niidome Y.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 18,
      "context" : "[19] Smith BR, GhosnEliver Eid B, Rallapalli H, Prescher JA, Larson T, Herzenberg LA, et al.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 19,
      "context" : "[20] Kim H, Namgung R, Singha K, Oh I-K, Kim WJ.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 21,
      "context" : "[22] Robinson JT, Tabakman SM, Liang Y, Wang H, Sanchez Casalongue H, Vinh D, et al.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 22,
      "context" : "[23] Su S, Wang J, Wei J, Martinez-Zaguilan R, Qiu J, Wang S.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 23,
      "context" : "[24] Li J-L, Hou X-L, Bao H-C, Sun L, Tang B, Wang J-F, et al.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 24,
      "context" : "[25] Burke A, Ding X, Singh R, Kraft RA, Levi-Polyachenko N, Rylander MN, et al.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 25,
      "context" : "[27] Kam NWS, O'Connell M, Wisdom JA, Dai H.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 26,
      "context" : "[28] Yang K, Zhang S, Zhang G, Sun X, Lee S-T, Liu Z.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 27,
      "context" : "[29] Su S, Wang J, Wei J, Martinez-Zaguilan R, Qiu J, Wang S.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 28,
      "context" : "[30] Akhavan O, Ghaderi E, Aghayee S, Fereydooni Y, Talebi A.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 30,
      "context" : "[32] Murakami T, Nakatsuji H, Inada M, Matoba Y, Umeyama T, Tsujimoto M, et al.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 31,
      "context" : "[33] Ge J, Lan M, Zhou B, Liu W, Guo L, Wang H, et al.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 32,
      "context" : "[34] Markovic ZM, Ristic BZ, Arsikin KM, Klisic DG, Harhaji-Trajkovic LM, Todorovic-Markovic BM, et al.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 34,
      "context" : "[36] Marcano DC, Kosynkin DV, Berlin JM, Sinitskii A, Sun Z, Slesarev A, et al.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 35,
      "context" : "[37] Vankayala R, Kuo C-L, Sagadevan A, Chen P-H, Chiang C-S, Hwang KC.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 36,
      "context" : "[38] Li J-L, Bao H-C, Hou X-L, Sun L, Wang X-G, Gu M.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 37,
      "context" : "[39] Pramanik A, Chavva SR, Fan Z, Sinha SS, Nellore BPV, Ray PC.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 39,
      "context" : "[41] Habash RWY, Bansal R, Krewski D, Alhafid HT.",
      "startOffset" : 0,
      "endOffset" : 4
    } ],
    "year" : 2016,
    "abstractText" : "Cancer is one of the major life-threatening diseases among human beings. Developing a simple, cost-effective and biocompatible approach to treat cancers using ultra-low doses of light is a grand challenge in clinical cancer treatments. In this study, we report for the first time that nano-sized graphene oxide (GO) exhibits single-photon excitation wavelength dependent photoluminescence in the visible and short near-infrared (NIR) region, suitable for in vivo multi-color fluorescence imaging. We also demonstrate in both in vitro and in vivo experiments to show that nano GO can sensitize the formation of singlet oxygen to exert combined nanomaterial-mediated photodynamic therapeutic (NmPDT) and photothermal therapy (NmPTT) effects on the destruction of B16F0 melanoma tumors in mice using ultra-low doses (~0.36 W/cm) of NIR (980 nm) light. The average half-life span of the mice treated by the GO-PEG-folate-mediated NmPDT effects is beyond 30 days, which is ~1.8 times longer than the mice treated with doxorubicin (17 days). Overall, the current study points out a successful example of using GO-PEG-folate nanocomposite as a theranostic nanomedicine to exert simultaneously in vivo fluorescent imaging as well as combined NmPDT and NmPTT effects for clinical cancer treatments.",
    "creator" : "Elsevier"
  }
}